EMA reviewing data after reports of suicidal thoughts and thoughts of self-harm after taking GLP-1a The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is reviewing data on the risk of suicidal...
Drug combination could improve glucose and weight control in diabeticsScientists from Hyderabad, India, have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour19 hours ago